Harvard Women's Health Watch

Research we're watching: Drug cuts breast cancer risk by more than half

The aromatase inhibitor drug anastrozole (Arimidex) reduces the chance of developing breast cancer by 53% in postmenopausal women at high risk for the disease.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In